H20-HEALTH-Health, demographic change and wellbeing
Simulation of Cardiac Devices & Drugs for in-silico Testing and Certification
Despite massive investment in healthcare, huge R&D cost increase and regulatory pathway complexity hamper tremendously commercialisation of new devices & medicines, putting patient populations at risk of not receiving adequate therapy. At the same time, outside healthcare, computer modelling and ...